跳转至内容
Merck
  • Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.

Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.

The Journal of pharmacology and experimental therapeutics (2014-07-16)
Lise Román Moltzau, Jan Magnus Aronsen, Silja Meier, Jonas Skogestad, Øivind Ørstavik, Gustav B Lothe, Ivar Sjaastad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy, Eirik Qvigstad
摘要

We previously found a negative inotropic (NIR) and positive lusitropic response (LR) to C-type natriuretic peptide (CNP) in the failing heart ventricle. In this study, we investigated and compared the functional responses to the natriuretic peptides (NPs), brain (BNP) and C-type natriuretic peptide (CNP), and relate them to cGMP regulation and effects on downstream targets. Experiments were conducted in left ventricular muscle strips and ventricular cardiomyocytes from Wistar rats with heart failure 6 weeks after myocardial infarction. As opposed to CNP, BNP did not cause an NIR or LR, despite increasing cGMP levels. The BNP-induced cGMP elevation was mainly and markedly regulated by phosphodiesterase (PDE) 2 and was only marginally increased by PDE3 or PDE5 inhibition. Combined PDE2, -3, and -5 inhibition failed to reveal any functional responses to BNP, despite an extensive cGMP elevation. BNP decreased, whereas CNP increased, the amplitude of the Ca(2+) transient. BNP did not increase phospholamban (PLB) or troponin I (TnI) phosphorylation, Ca(2+) extrusion rate constant, or sarcoplasmatic reticulum Ca(2+) load, whereas CNP did. Both BNP and CNP reduced the peak of the L-type Ca(2+) current. Cyclic GMP elevations by BNP and CNP in cardiomyocytes were additive, and the presence of BNP did not alter the NIR to CNP or the CNP-induced PLB and TnI phosphorylation. However, a small increase in the LR to maximal CNP was observed in the presence of BNP. In conclusion, different responses to cGMP generated by BNP and CNP suggest different compartmentation of the cGMP signal and different roles of the two NPs in the failing heart.

材料
货号
品牌
产品描述

Sigma-Aldrich
阿托品 硫酸盐 一水合物, ≥97% (TLC), crystalline
Sigma-Aldrich
哌唑嗪 盐酸盐, ≥99.0% (HPLC)
Sigma-Aldrich
鸟苷-3′,5′-环一磷酸 钠盐, ≥99% (HPLC), powder
USP
阿托品盐酸盐标准液, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
鸟苷 3',5'-环单磷酸, ≥98% (HPLC), powder
Sigma-Aldrich
噻吗洛尔 马来酸盐, ≥98% (TLC), powder
Supelco
硫酸阿托品, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
环己喹酰胺, phosphodiesterase inhibitor
USP
哌唑嗪 盐酸盐, United States Pharmacopeia (USP) Reference Standard
异氟醚, European Pharmacopoeia (EP) Reference Standard
马来酸替莫洛尔, European Pharmacopoeia (EP) Reference Standard
西地那非, European Pharmacopoeia (EP) Reference Standard
阿托品 硫酸盐 一水合物, European Pharmacopoeia (EP) Reference Standard
哌唑嗪 盐酸盐, European Pharmacopoeia (EP) Reference Standard
用于系统适应性的噻吗洛尔, European Pharmacopoeia (EP) Reference Standard